Agilent Technologies raised its annual adjusted profit forecast to a range of $6.18 to $6.21 per share on Wednesday morning, driven by recovering lab research demand. The upward revision follows a prolonged sector downturn across the United States marked by constrained biotechnology funding. Investors responded to strengthening end markets, pushing shares higher as third-quarter results beat consensus estimates.

Revenue and Profit Beats